← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2011Last known activity
Jan 31, 2024
Timeline
2000s
- Jun 1, 2006
Polaris Group— Founded
Drugs by trial phase (12 distinct, 24 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Recent trials (28)
- NCT05813327CollaboratorPhase 1/Phase 2Jan 31, 2024
- NCT05842512Study directorPhase 2Nov 30, 2023
- NCT05842512Lead sponsorPhase 2Nov 30, 2023
- NCT05712694Study directorPhase 3Nov 29, 2023
- NCT05712694Lead sponsorPhase 3Nov 29, 2023
- NCT05616624CollaboratorPhase 1/Phase 2Jan 31, 2023
- NCT05317819Study directorPhase 3Mar 14, 2022
- NCT05317819Lead sponsorPhase 3Mar 14, 2022
- NCT05001828Lead sponsorPhase 1Aug 31, 2021
- NCT04587830Lead sponsorPhase 1Jun 16, 2020
- NCT03498222CollaboratorPhase 1Jun 1, 2018
- NCT03254732Lead sponsorPhase 1Jul 14, 2017
- NCT02709512Lead sponsorPhase 2/Phase 3Oct 1, 2016
- NCT02875093Lead sponsorPhase 1Sep 1, 2016
- NCT02101580Lead sponsorPhase 1Nov 1, 2014
Details
- Founded
- San Diego, CA, US Jun 1, 2006
- Last known activity
- Jan 31, 2024